Fig. 1From: SESN2 correlates with advantageous prognosis in hepatocellular carcinomaOne-step quantitative real-time polymerase chain reaction (qPCR) test was performed to examine SESN2 expression in hepatocellular carcinoma (HCC) and non-cancerous tissues. The SESN2 mRNA expression was statistically lower in HCC tissues (1.73 ± 0.165) than that of in the corresponding noncancerous tissues (2.34 ± 0.145) (* p < 0.05.)Back to article page